Skip to content
WeighLab
Menu
Ranked #142 · Grade C

AskRx review

AskRx is a US telehealth platform whose board-certified physicians exclusively prescribe FDA-approved, brand-name GLP-1 medications for weight loss - no compounded drugs.

Visit AskRx Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$349/mo (all doses, brand-name)
Tirzepatide
$299/mo (2.5 mg dose, brand-name)
Coverage
All 50 states
Brand-name
Yes

Semaglutide · modeled / year

$4,188

Tirzepatide · modeled / year

$3,588

The Index scorecard

AskRx scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month39/100
Price Transparency86/100
Nationwide Access86/100
Formulation Options79/100
Clinical Oversight82/100
Contract Flexibility20/100

Where the value is

  • Prescribes only FDA-approved brand-name GLP-1s, no compounded drugs
  • LegitScript approved and HIPAA compliant
  • Board-certified physicians trained in obesity medicine
  • Transparent dose-based pricing published on site
  • Available in all 50 states

The tradeoffs

  • Cash-pay model; medication cost billed separately by the pharmacy
  • Does not dispense medication itself, so fulfillment depends on third-party pharmacies
  • No compounded lower-cost alternative offered
  • Specific list of supported states is not published

The bottom line

Best for: People who want a brand-name-only GLP-1 prescriber routing to NovoCare or LillyDirect. AskRx is a US telehealth platform whose board-certified physicians exclusively prescribe FDA-approved, brand-name GLP-1 medications for weight loss - no compounded drugs.

Ranked #142 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to AskRx.

The 18 programs nearest this one

Pricing, states and verification reflect AskRx's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on AskRx's site. Not medical advice; see our disclosure.

← Back to the value leaderboard